Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference

NEW BRUNSWICK, N.J., Nov. 28, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Piper Jaffray 23rd Annual Health Care Conference on Tuesday, Nov. 29th at The New York Palace, New York, NY.  Gary Pruden, Company Group Chairman, Ethicon will present in a session scheduled at 8:00 a.m. (Eastern Time).

The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

  

 

 

SOURCE Johnson & Johnson

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.